166 related articles for article (PubMed ID: 10784033)
1. Short synthetic glycopeptides successfully induce antibody responses to carcinoma-associated Tn antigen.
Vichier-Guerre S; Lo-Man R; Bay S; Deriaud E; Nakada H; Leclerc C; Cantacuzène D
J Pept Res; 2000 Feb; 55(2):173-80. PubMed ID: 10784033
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope.
Lo-Man R; Vichier-Guerre S; Bay S; Dériaud E; Cantacuzène D; Leclerc C
J Immunol; 2001 Feb; 166(4):2849-54. PubMed ID: 11160353
[TBL] [Abstract][Full Text] [Related]
3. The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients.
Rosenbaum P; Artaud C; Bay S; Ganneau C; Campone M; Delaloge S; Gourmelon C; Loirat D; Medioni J; Pein F; Sablin MP; Tredan O; Varga A; Leclerc C
Cancer Immunol Immunother; 2020 May; 69(5):703-716. PubMed ID: 32034426
[TBL] [Abstract][Full Text] [Related]
4. A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates.
Lo-Man R; Vichier-Guerre S; Perraut R; Dériaud E; Huteau V; BenMohamed L; Diop OM; Livingston PO; Bay S; Leclerc C
Cancer Res; 2004 Jul; 64(14):4987-94. PubMed ID: 15256473
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen.
Vichier-Guerre S; Lo-Man R; Huteau V; Dériaud E; Leclerc C; Bay S
Bioorg Med Chem Lett; 2004 Jul; 14(13):3567-70. PubMed ID: 15177475
[TBL] [Abstract][Full Text] [Related]
6. Induction of carbohydrate-specific antibodies in HLA-DR transgenic mice by a synthetic glycopeptide: a potential anti cancer vaccine for human use.
Vichier-Guerre S; Lo-Man R; BenMohamed L; Dériaud E; Kovats S; Leclerc C; Bay S
J Pept Res; 2003 Sep; 62(3):117-24. PubMed ID: 12895273
[TBL] [Abstract][Full Text] [Related]
7. The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity.
Laubreton D; Bay S; Sedlik C; Artaud C; Ganneau C; Dériaud E; Viel S; Puaux AL; Amigorena S; Gérard C; Lo-Man R; Leclerc C
Cancer Immunol Immunother; 2016 Mar; 65(3):315-25. PubMed ID: 26847142
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer.
Mazal D; Lo-Man R; Bay S; Pritsch O; Dériaud E; Ganneau C; Medeiros A; Ubillos L; Obal G; Berois N; Bollati-Fogolin M; Leclerc C; Osinaga E
Cancer Immunol Immunother; 2013 Jun; 62(6):1107-22. PubMed ID: 23604173
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn.
Kagan E; Ragupathi G; Yi SS; Reis CA; Gildersleeve J; Kahne D; Clausen H; Danishefsky SJ; Livingston PO
Cancer Immunol Immunother; 2005 May; 54(5):424-30. PubMed ID: 15625606
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and immunological evaluation of a MUC1 glycopeptide incorporated into l-rhamnose displaying liposomes.
Sarkar S; Salyer AC; Wall KA; Sucheck SJ
Bioconjug Chem; 2013 Mar; 24(3):363-75. PubMed ID: 23444835
[TBL] [Abstract][Full Text] [Related]
11. Preparation of a multiple antigen glycopeptide (MAG) carrying the Tn antigen. A possible approach to a synthetic carbohydrate vaccine.
Bay S; Lo-Man R; Osinaga E; Nakada H; Leclerc C; Cantacuzène D
J Pept Res; 1997 Jun; 49(6):620-5. PubMed ID: 9266491
[TBL] [Abstract][Full Text] [Related]
12. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
Sørensen AL; Reis CA; Tarp MA; Mandel U; Ramachandran K; Sankaranarayanan V; Schwientek T; Graham R; Taylor-Papadimitriou J; Hollingsworth MA; Burchell J; Clausen H
Glycobiology; 2006 Feb; 16(2):96-107. PubMed ID: 16207894
[TBL] [Abstract][Full Text] [Related]
13. Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen.
Buskas T; Ingale S; Boons GJ
Angew Chem Int Ed Engl; 2005 Sep; 44(37):5985-8. PubMed ID: 16108081
[No Abstract] [Full Text] [Related]
14. Isolation and characterization of antibodies against three consecutive Tn-antigen clusters from a phage library displaying human single-chain variable fragments.
Sakai K; Yuasa N; Tsukamoto K; Takasaki-Matsumoto A; Yajima Y; Sato R; Kawakami H; Mizuno M; Takayanagi A; Shimizu N; Nakata M; Fujita-Yamaguchi Y
J Biochem; 2010 Jun; 147(6):809-17. PubMed ID: 20147453
[TBL] [Abstract][Full Text] [Related]
15. Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128).
Nakada H; Inoue M; Numata Y; Tanaka N; Funakoshi I; Fukui S; Mellors A; Yamashina I
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2495-9. PubMed ID: 7681597
[TBL] [Abstract][Full Text] [Related]
16. Surface plasmon resonance and NMR analyses of anti Tn-antigen MLS128 monoclonal antibody binding to two or three consecutive Tn-antigen clusters.
Matsumoto-Takasaki A; Hanashima S; Aoki A; Yuasa N; Ogawa H; Sato R; Kawakami H; Mizuno M; Nakada H; Yamaguchi Y; Fujita-Yamaguchi Y
J Biochem; 2012 Mar; 151(3):273-82. PubMed ID: 22161472
[TBL] [Abstract][Full Text] [Related]
17. T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity.
Galli-Stampino L; Meinjohanns E; Frische K; Meldal M; Jensen T; Werdelin O; Mouritsen S
Cancer Res; 1997 Aug; 57(15):3214-22. PubMed ID: 9242452
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the fine specificity of Tn-binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectroscopy.
Osinaga E; Bay S; Tello D; Babino A; Pritsch O; Assemat K; Cantacuzene D; Nakada H; Alzari P
FEBS Lett; 2000 Mar; 469(1):24-8. PubMed ID: 10708749
[TBL] [Abstract][Full Text] [Related]
19. Glycosylation of the tandem repeat unit of the MUC2 polypeptide leading to the synthesis of the Tn antigen.
Inoue M; Yamashina I; Nakada H
Biochem Biophys Res Commun; 1998 Apr; 245(1):23-7. PubMed ID: 9535776
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope.
Peri F; Cipolla L; Rescigno M; La Ferla B; Nicotra F
Bioconjug Chem; 2001; 12(3):325-8. PubMed ID: 11353527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
